Evidence Vault

The clinical evidence gap is not only a failure to adopt new, beneficial treatments but also a persistent inability to "de-adopt" practices proven to be ineffective. Millions, and often billions, of dollars are wasted on clinical interventions that persist simply because the healthcare system lacks the structural mechanisms to remove them from routine practice. This systemic inertia keeps non-beneficial treatments in use long after high-quality evidence has demonstrated their lack of value. The Persistence of Low-Value Care Traditional implementation science treats the transfer of knowledge as a linear problem—moving information from a research publication to a clinical setting. This linear approach is insufficient for de-adoption because it relies on individual clinician awareness and administrative oversight rather than an integrated system of change. Consequently, outdated practices remain embedded in standard care for decades. Examples of this waste include: • Bone Cement for Spine Fractures: Research indicates no clinical benefit for its use in osteoporosis-related spine fractures, yet the practice continues to consume significant healthcare resources. • Cervical Cancer Screening: Routine screening in women under 30 is widely recognized as providing no benefit, yet it remains a persistent clinical activity. Without a structural way to link new evidence directly to clinical behavior, these non-beneficial practices remain a financial and clinical liability. The Circle Dataset Intervention: Integrated Architecture for Real-Time De-adoption A primary feature of Circle Datasets is the creation of an integrated architecture where evidence generation and clinical practice occur simultaneously. Unlike traditional methods that treat research as a separate, retrospective activity, the Circle Platform utilizes a prospective, protocol-driven framework. By utilizing the Observational Protocol (OP), health systems can define clinical benchmarks and "de-adoption" triggers based on real-world evidence from the moment data is collected . Because these datasets are "regulatory-ready" at the time of completion, they provide the verifiable, deterministic evidence required to justify rapid shifts in clinical guidelines and payer coverage. This structural mechanism allows healthcare executives to bypass the 17-year wait for evidence synthesis and systematically eliminate wasteful practices based on the latest verified data

The Death of the Data Code of Honor For most of modern medicine, data governance has been an article of faith. Institutions promised to “protect privacy” and “ensure ethical use” — but those promises were procedural, not structural. Ethics lived in policy manuals, not in code. As data volume and velocity exploded, good intentions failed at scale. Consent became unreadable, privacy untraceable, and accountability fragmented across vendors. Governance by paperwork collapsed under the weight of automation. The next generation of trust cannot depend on belief; it must depend on architecture. From Declarations to Design Stewardship begins where policy meets infrastructure. It requires that ethical rules be executable, not merely aspirational. In federated systems such as Circle Datasets, this means embedding oversight directly into the data fabric: access controls enforced by smart contracts, audit logs written immutably to every transaction, metadata that records purpose, consent status, and jurisdiction. Ethics is not written once; it is executed continuously. Governance ceases to be a meeting — it becomes a protocol. The Architecture of Accountability Federated stewardship transforms the old hierarchy of control. Instead of a central authority managing compliance after the fact, each node enforces its own governance locally under a harmonized framework. This achieves what no centralized database could: autonomy with alignment. Every participant knows their obligations, sees their own compliance in real time, and contributes transparently to the shared ledger of trust. The network as a whole becomes self-documenting — a living constitution for data. In Circle systems, governance is not centralized oversight; it is distributed conscience. Policy as Code The practical expression of stewardship is policy as code — converting ethical and legal standards into machine-readable rules. Access conditions, retention limits, and consent revocations can all be enforced algorithmically. This eliminates the interpretive gap between regulation and implementation. A hospital in California, a clinic in Berlin, and a university in Seoul can all operate under identical policy logic while maintaining national sovereignty. The code becomes the treaty. The result is not just consistency but moral precision: rules enforced exactly as written, without bias or exception. Continuous Compliance Traditional audits occur annually; federated systems audit themselves continuously. Every data use event leaves a cryptographically verifiable footprint — a proof of compliance visible to regulators, partners, and patients alike. This transforms governance from retrospective to anticipatory. Misuse cannot accumulate unnoticed; the system detects and corrects it before damage occurs. Stewardship thus evolves from record-keeping to risk prevention. The Human Dimension Even perfect automation requires human participation. Federated stewardship preserves the clinician’s role as moral agent — the one who understands not just what the data says, but what it means. By giving each site the authority to enforce its own ethics, Circle Datasets ensure that local values and global standards remain in dialogue. Governance becomes culturally adaptive, not homogenizing — a network of aligned responsibilities rather than a hierarchy of permissions. This is the opposite of bureaucracy. It is digital subsidiarity: power staying as close as possible to knowledge. The Economic Dividend Governance is often seen as cost. In practice, it is capital. Systems that demonstrate traceable compliance attract regulators, insurers, and investors because they convert ethical certainty into financial predictability. A governed dataset is not only safer — it is auditable collateral. Stewardship turns ethics into infrastructure and infrastructure into value. The Moral Outcome Stewardship succeeds when governance becomes invisible — when the right thing happens automatically. In that sense, the highest form of regulation is not constraint but design: a system so well built that it prevents wrongdoing by structure, not surveillance. Federated architectures make that possible. They translate morality into mathematics and intention into mechanism — proving that ethics, like engineering, can scale.

The global landscape for clinical evidence is undergoing a fundamental shift as regulatory agencies and payers move away from static clinical trial results toward continuous post-market surveillance streams. This transition is driven by the increasing necessity for longitudinal data to support drug and device approvals, particularly in an environment where traditional single-arm trials face higher levels of scrutiny. The Rising Mandate for Real-World Evidence Regulatory adoption of Real-World Evidence (RWE) has accelerated significantly over the last several years. The proportion of FDA approvals containing RWE increased from approximately 5% to 10% in 2020 to nearly 50% by 2024. This shift is not merely a change in preference but a structural requirement; regulatory agencies are now frequently rejecting single-arm trials that lack synthetic control arms derived from longitudinal health records. The economic implications of this shift are reflected in the projected growth of the RWE solutions market, which was estimated at $2.6 billion in 2025 and is expected to reach $12 billion by 2035. Furthermore, cloud-based deployment models now capture approximately 64% of the market, as they provide the elastic computing power and pricing models required for large-scale data analysis. The Circle Dataset Intervention: Federated Data Capture and Regulatory Readiness A primary challenge in meeting these new regulatory standards is the difficulty of accessing verifiable, high-quality longitudinal data that remains compliant with global privacy and residency requirements. Circle Datasets address this through the Federated Healthcare Data Capture model. A key feature of this model is that clinical data remains at the primary point of care—ensuring compliance with data residency laws—while being accessible for analysis via secure, cloud-based infrastructure. This architecture ensures that the resulting datasets are verifiable, unambiguously owned, and "regulatory-ready". This provides drug and device manufacturers with the synthetic control arms now essential for securing FDA approval. By adopting this prospective architecture, health systems can transform their data from a liability into a capital asset that benefits providers, patients, and payers alike.

The primary bottleneck in the clinical translation process is the resource-intensive nature of traditional systematic reviews. These reviews, which form the definitive basis for medical textbooks and clinical guidelines, typically require years to complete. This delay ensures that by the time evidence is formally synthesized and reaches the point of care, the underlying data may already be outdated. This linear, non-collaborative workflow is a fundamental driver of the 17-year evidence-to-practice gap. The Challenges of Manual Synthesis Manual literature screening and data extraction are limited by human capacity and are prone to significant sensitivity gaps. The volume of biomedical research is now so vast that updating even a small subset of clinical reviews can involve screening hundreds of thousands of citations. • Temporal Lag: The average duration to move from a publication to its inclusion in a systematic review or textbook is 6.3 years. • Human Error: Human reviewers typically achieve approximately 82% sensitivity in literature screening, leaving a 18% margin for missed evidence. • Resource Exhaustion: Systematic reviews are often delayed or left un-updated due to the extreme resource intensity required for manual synthesis. The Circle Dataset Intervention: Structured AI Orchestration A primary feature of Circle Datasets is the production of structured, standardized outputs specifically designed for seamless integration into AI-assisted evidence synthesis. By utilizing protocol-driven, deterministic data rather than unstructured electronic health record (EHR) scrapes, the platform provides the high-quality foundation necessary for Large Language Models (LLMs) to perform synthesis without the risk of hallucination. This integration enables the technical reality of Evidence-as-a-Service: • Synthesis Velocity: LLM-based approaches, such as the "otto-SR" system, have demonstrated the ability to update 12 Cochrane reviews—analyzing 146,276 citations—in under 48 hours. • Superior Precision: Automated systems have demonstrated a 97% sensitivity in literature screening, exceeding human performance by 15%. • Point-of-Care Delivery: Because Circle Datasets are built on interoperable mappings (such as FHIR and USCDI), the synthesized evidence can be delivered as context-aware updates directly into the EHR at the point of care. This architectural shift transforms clinical evidence from a static, retrospective document into a dynamic infrastructure that continuously updates the medical knowledge base in near-real-time .

In the legacy healthcare data economy, patients are often viewed as passive subjects whose information is extracted and monetized by third-party intermediaries without their explicit consent or financial benefit . This extraction model erodes trust and fails to acknowledge that personal healthcare data are "rights-laden emanations of the person" that should be protected as a human right. Furthermore, patients face significant financial pressure, with high out-of-pocket costs remaining a primary concern for 71% of consumers. The Crisis of Trust and Privacy As younger generations become more digitally proactive—with 75% to 80% using health technology monthly—there is a growing demand for a "digital social contract" grounded in dignity and participation . The current centralized storage of medical records increases the risk of large-scale data breaches and identity theft. Patients frequently have no visibility into how their data is used or whether it contributes to clinical practices that are actually effective for their specific conditions. The Circle Dataset Intervention: Self-Sovereign Identity and Data Dividends A primary feature of Circle Datasets is the integration of Self-Sovereign Identity (SSI) and the Circle Health Coin to return control and value to the patient.

Health insurance payers are currently facing significant upward pressure from rising medical costs, with trends projected at 8% to 9% through the end of 2026. A critical metric in this environment is the Medical Loss Ratio (MLR)—the specific percentage of premium income dedicated to medical claims. To manage this ratio effectively, payers must distinguish between clinical interventions that demonstrate genuine efficacy in diverse populations and those that only show results in highly controlled environments. The Limitation of Idealized Clinical Trials A primary challenge for payers is the "efficacy gap"—the discrepancy between how a drug or procedure performs in an idealized clinical trial versus how it performs in the general patient population. Traditional data sources often lack the granularity to identify why certain high-cost therapies fail to meet clinical markers in real-world settings. A primary feature of Circle Datasets is the provision of deterministic longitudinal data, which allows payers to transition from reactive claims processing to proactive risk management. By tracking a patient’s journey through a standardized protocol, Circle Datasets provide the verifiable evidence needed to negotiate outcome-based agreements with manufacturers. For example, in the management of high-cost specialty drugs, payers can use the deterministic evidence within a Circle Dataset to trigger rebates if a drug fails to meet specific clinical markers, such as HbA1C levels. Furthermore, the integration of structured Circle Datasets into AI-driven analysis can reduce fraud and waste by up to 50% by ensuring that all risk-adjustment documentation is fully supported by protocol-driven clinical evidence. This structural shift allows payers to stabilize their MLR by eliminating spending on ineffective therapies and ensuring high-precision risk adjustment.